FDA approves Eliquis for leg, lung blood clot treatment

The U.S. FDA approved the use of Eliquis as an effective alternative treatment for DVT and PE conditions. Eliquis is a byproduct of a collaborative work between Bristol-Myers Squibb and Pfizer.